Abcellera Biologics
-$1.35 (-5.21%) Today
+$0.30 (+1.22%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell ABCL and other stocks, options, and ETFs commission-free!
About ABCL
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.
CEO
Carl Lars G. Hansen
Employees
206
Headquarters
Vancouver, British Columbia
Founded
2012
ABCL Key Statistics
Market Cap
6.69B
Price-Earnings Ratio
29.39
Dividend Yield
—
Average Volume
2.07M
High Today
$26.60
Low Today
$24.20
Open Price
$26.60
Volume
3.57M
52 Week High
$71.91
52 Week Low
$23.20
ABCL Earnings
$0.00
$0.20
$0.41
$0.61
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours